4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-026392
Options or other derivatives
- SVP Research & Product Dev. acquired 116,524 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wu Hua SVP Research & Product Dev. | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +58,161 | 58,161 | D: show line 1 in the form | ||
| Wu Hua SVP Research & Product Dev. | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +14,540 | 14,540 | D: show line 2 in the form | ||
| Wu Hua SVP Research & Product Dev. | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +6,979 | 6,979 | D: show line 3 in the form | ||
| Wu Hua SVP Research & Product Dev. | 2021-10-22 | Grant or award · Earnout Rights (Restricted Stock Units) | +32,191 | 32,191 | D: show line 4 in the form | ||
| Wu Hua SVP Research & Product Dev. | 2021-10-22 | Grant or award · Employee Stock Option (right to buy) | +4,653 | 4,653 | I: show line 5 in the form |
Loading xslF345X03/ownership.xml…